The Valley Desk

NCT01472562 · Interventional trial

Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma

Overall registry status Completed

Phase 2

Conditions Mantle Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov